NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com

StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Trading Down 3.5 % Shares of NURO stock opened at $3.57 on Tuesday. The business’s 50 day moving average is $3.76 […]

Leave a Reply

Your email address will not be published.

Previous post Red Sox point-counterpoint: How should Boston, Breslow approach the all-important trade deadline?
Next post Graham (NYSE:GHM) Downgraded by StockNews.com